U.S. Markets open in 7 hrs, 21 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 0.74 09:34 AM EST | |
|---|---|---|
| Day High | 0.80 09:58 AM EST |
|
| Range | 0.06 |
| Volume | 53.89 M | |
|---|---|---|
| 30-Day Avg Vol | 16.76 M |
|
| Difference | 221.55% |
| Market Cap | 444.31 M | |
|---|---|---|
| Mkt Cap Chg | 76.68 M |
| Shares Out | 574.42 M | |
|---|---|---|
| % Shrs Traded | 9.38% | |
| 1yr EPS Est | -0.08 |
| 52-Wk Low | 0.05 | |
|---|---|---|
| 52-Wk High | 2.23 |
|
| Range | 2.18 |
| Prev Close | 0.64 2/8/10 | |
|---|---|---|
| Today's Open | 0.7541 | |
| Change | 17.83% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 54.39 M |
| Revenue (LFY) | 11.43 M | |
|---|---|---|
| Earnings (LFY) | -180.03 M | |
| Earnings (MRQ) | -35.02 M | |
| Next Earn Est | -0.03 | |
| Next Earnings | 02/11/2010 |
|
| EPS (TTM) | -1.64 | |
| 1yr EPS Growth | 88.89% |
| P/E Ratio (TTM) | 0.12 | |
|---|---|---|
| P/E Ratio (Fwd) | -9.00 | |
| PEG Ratio | — | |
| Return on Equity | — | |
| Beta | 7.20 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Cell Therapeutics (CTI) is a toxic avenger. The firm creates more effective and less toxic treatments for various forms of cancer. CTI is also developing a number of other cancer-fighting compounds, including ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.03 2/11/10 | — — |
—
—
|
| Last Quarter | — 9/30/09 | -0.09 9/30/09 |
—
—
|
| 2 Quarters Ago | -0.05 6/30/09 | -0.06 6/30/09 |
-0.01
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 20,000.00 | 11.43 M |
| Gross Profit | 842,000.00 | 2.96 M |
| Operating Income | -27.43 M | -86.69 M |
| Net Income | -35.02 M | -180.03 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts